Concentrix Corporation (CNXC)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NASDAQ
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 11:05 AM ET
Concentrix Corporation (CNXC) Earnings: Report Dates and Results
Concentrix (CNXC) is expected to report earnings on Jan 11, 2027. In the quarter ended Aug 31, 2026, Concentrix reported EPS of $2.57, above the $2.40 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CNXC has an expected report date of Jan 11, 2027. Analysts' consensus for the quarter ending Nov 30, 2026 is 1.0% above the $2.95 reported for the quarter ended Nov 30, 2025.
CNXC Earnings Call
The latest CNXC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 25 quarters below that had an estimate, CNXC beat 15 and missed 10. Revenue for the quarter ended Aug 31, 2026 was $2.45B, down 1.2% from $2.48B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | $2.57 | $2.40 | N/A | +7.08% | Beat | -7.6% | 3 | 0 up, 3 down | Sep 29, 2026 | $2.45B |
| May 31, 2026 | $2.32 | $2.31 | N/A | +0.43% | Beat | -14.1% | 4 | 0 up, 3 down | Jun 29, 2026 | $2.46B |
| Feb 28, 2026 | $2.61 | $2.65 | $2.63 - $2.66 | -1.51% | Miss | -6.5% | 4 | 0 up, 2 down | Mar 24, 2026 | $2.50B |
| Nov 30, 2025 | $2.95 | $2.91 | $2.89 - $2.94 | +1.37% | Beat | -9.5% | 4 | 0 up, 3 down | Jan 13, 2026 | $2.55B |
| Aug 31, 2025 | $2.78 | $2.87 | $2.84 - $2.90 | -3.14% | Miss | -3.1% | 5 | 1 up, 1 down | Sep 25, 2025 | $2.48B |
| May 31, 2025 | $2.70 | $2.75 | $2.71 - $2.77 | -1.82% | Miss | +0.4% | 5 | 1 up, 0 down | Jun 26, 2025 | $2.42B |
| Feb 28, 2025 | $2.79 | $2.59 | $2.54 - $2.66 | +7.72% | Beat | +8.6% | 4 | 0 up, 1 down | Mar 26, 2025 | $2.37B |
| Nov 30, 2024 | $3.26 | $3.01 | $2.95 - $3.06 | +8.38% | Beat | -3.0% | 5 | 0 up, 3 down | Jan 15, 2025 | $2.45B |
| Aug 31, 2024 | $2.87 | $2.93 | $2.90 - $2.97 | -2.05% | Miss | +5.9% | 4 | 0 up, 0 down | Sep 25, 2024 | $2.39B |
| May 31, 2024 | $2.69 | $2.63 | $2.62 - $2.63 | +2.28% | Beat | 0.0% | 4 | 0 up, 0 down | Jun 26, 2024 | $2.38B |
| Feb 29, 2024 | $2.57 | $2.58 | $2.57 - $2.59 | -0.39% | Miss | +0.4% | 4 | 0 up, 0 down | Mar 26, 2024 | $2.40B |
| Nov 30, 2023 | $3.36 | $3.08 | $3.06 - $3.10 | +9.09% | Beat | +11.6% | 3 | 0 up, 0 down | Jan 24, 2024 | $2.23B |
| Aug 31, 2023 | $2.71 | $2.83 | $2.71 - $2.96 | -4.24% | Miss | -8.1% | 4 | 0 up, 0 down | Sep 27, 2023 | $1.63B |
| May 31, 2023 | $2.69 | $2.75 | N/A | -2.18% | Miss | -8.2% | 3 | 0 up, 0 down | Jun 28, 2023 | $1.61B |
| Feb 28, 2023 | $2.56 | $2.60 | $2.53 - $2.66 | -1.54% | Miss | -10.2% | 2 | 0 up, 0 down | Mar 29, 2023 | $1.64B |
| Nov 30, 2022 | $3.01 | $3.33 | $3.31 - $3.35 | -9.61% | Miss | +0.7% | 2 | 0 up, 0 down | Jan 19, 2023 | $1.64B |
| Aug 31, 2022 | $2.95 | $2.97 | $2.93 - $3.01 | -0.67% | Miss | +18.5% | 2 | 0 up, 0 down | Sep 28, 2022 | $1.58B |
| May 31, 2022 | $2.93 | $2.82 | $2.82 - $2.86 | +3.90% | Beat | +23.6% | 2 | 0 up, 0 down | Jun 27, 2022 | $1.57B |
| Feb 28, 2022 | $2.85 | $2.71 | $2.70 - $2.74 | +5.17% | Beat | +24.5% | 3 | 0 up, 0 down | Mar 29, 2022 | $1.54B |
| Nov 30, 2021 | $2.99 | $2.71 | $2.68 - $2.74 | +10.33% | Beat | +44.4% | 3 | 0 up, 0 down | Jan 18, 2022 | $1.47B |
| Aug 31, 2021 | $2.49 | $2.24 | $2.23 - $2.25 | +11.16% | Beat | +28.4% | 3 | N/A | Sep 27, 2021 | $1.40B |
| May 31, 2021 | $2.37 | $2.27 | $2.24 - $2.29 | +4.41% | Beat | N/A | 3 | N/A | Jun 23, 2021 | $1.37B |
| Feb 28, 2021 | $2.29 | $2.11 | $2.03 - $2.13 | +8.53% | Beat | N/A | 2 | N/A | Mar 24, 2021 | $1.35B |
| Nov 30, 2020 | $2.07 | $2.03 | $1.98 - $2.08 | +1.97% | Beat | N/A | 2 | N/A | Jan 11, 2021 | $1.30B |
| Aug 31, 2020 | $1.94 | $1.54 | N/A | +25.97% | Beat | N/A | N/A | N/A | Sep 8, 2020 | $1.16B |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Aug 31, 2026 | $67.32 | +500.0% |
| Nov 30, 2025 | $11.22 | -1.5% |
| Nov 30, 2024 | $11.39 | +0.6% |
| Nov 30, 2023 | $11.32 | -3.6% |
| Nov 30, 2022 | $11.74 | +15.8% |
| Nov 30, 2021 | $10.14 | +152.9% |
| Nov 30, 2020 | $4.01 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,100 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,076 | 7 | |
| 2026Q2 | Jun 30, 2026 | 4,843 | 8 | |
| 2026Q1 | Mar 31, 2026 | 4,340 | 8 | |
| 2025Q4 | Dec 31, 2025 | 5,784 | 8 | |
| 2025Q3 | Sep 30, 2025 | 6,098 | 8 | |
| 2025Q2 | Jun 30, 2025 | 6,435 | 9 | |
| 2025Q1 | Mar 31, 2025 | 5,888 | 9 | |
| 2024Q4 | Dec 31, 2024 | 5,518 | 8 |
2026Q3 Earnings Call
Opening remarks
Elise Brassell Head of Corporate Communications and Investor Relations Thank you, operator, and welcome, everyone, to Concentrix' Third Quarter 2026 Earnings Call. This call is the property of Concentrix and may not be recorded or rebroadcast without the written permission of Concentrix. This call contains forward-looking statements that address our expected future performance and that, by their nature, address matters that are uncertain. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements as a result of new information or future expectations, events or developments. Please refer to today's earnings release and our most recent filings with the SEC for additional information regarding uncertainties that could affect our future financial results. This includes the risk factors provided in our annual report on our Form 10-K and in our other public filings with the SEC. Also, during the call, we will discuss non-GAAP financial measures, including adjusted free cash flow, non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP EPS and constant currency revenue growth. A reconciliation of these non-GAAP measures is available in the news release and on the company Investor Relations website under Financials. With me on the call today are Chris Caldwell, our President and Chief Executive Officer; and Andre Valentine, our Chief Financial Officer. Chris will provide a summary of our operating performance and growth strategy, and Andre will cover our financial results and business outlook. Then we'll open the call for your questions. Now I'll turn the call over to Chris.
Christopher Caldwell President and Chief Executive Officer Thank you, Elise. Hello, everyone, and thank you for joining us for our third quarter 2026 earnings call. I'm proud to start this call by recognizing a milestone that speaks to how far Concentrix has come over the last few years since generative AI was released and concerns for the viability of the services industry started. Over the last three years, we've steadily expanded the services we offer and invested in deployments of AI technology to evolve our business. This quarter, we crossed the mark that 50% of our revenue now comes from businesses we generated in the last three years that are very different from our traditional business. These new revenue sources are comprised of: $3 billion of revenue that is coming from new and existing clients that have either gone through heavy transformation or have AI influencing the revenue; $1.3 billion of net revenue resulting from the compression of our traditional services using our iX Suite AI platform; and finally, $700 million of revenue from new high-value services we brought to the market across growing segments like risk and compliance.
Frequently Asked Questions About CNXC
When is Concentrix's next earnings date?
Concentrix's next earnings report is expected for Jan 11, 2027.
Did CNXC beat earnings estimates last quarter?
Yes. Concentrix reported EPS of $2.57 for the quarter ended Aug 31, 2026, above the $2.40 estimate, a 7.08% surprise.
What EPS do analysts expect from CNXC next quarter?
The consensus EPS estimate for Concentrix for the quarter ending Nov 30, 2026 is $2.98 from 6 analysts, with estimates from $2.84 to $3.09.
How often does CNXC beat earnings estimates?
Concentrix beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +2.32%.
CNXC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts